Brain Stimulation for Age-Related Memory Decline

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May be covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Boston University Charles River Campus

No Placebo Group

Approved in 2 jurisdictions

Trial Summary

What is the purpose of this trial?The research program will evaluate the theoretical claim that age-related memory and cognitive decline in humans result from the inefficient orchestration of rhythmic activity within large-scale cortical networks. The results will contribute to the basic science groundwork for developing future non-pharmacological interventions aimed at boosting memory and cognition in aging and clinical populations.

Eligibility Criteria

This trial is for older adults aged 68-80 with normal cognitive function (as shown by specific mental exams), no psychoactive medication use, and good vision. They must not have electronic implants, metal in the head, skin sensitivity issues, depression, neurological problems or a history of head injury.

Inclusion Criteria

I have never had a head injury or neurological problems.

I am not on any psychoactive medication.

My vision, with or without glasses, is normal, including seeing colors.

Participant Groups

The study tests if high definition transcranial electrical current stimulation can improve memory and cognition in older adults by enhancing brain activity patterns. It's non-drug based and could lead to new treatments for age-related cognitive decline.

2Treatment groups

Experimental Treatment

Placebo Group

Group I: active stimulationExperimental Treatment1 Intervention

Group II: sham stimulationPlacebo Group1 Intervention

High definition transcranial electrical current stimulation is already approved in United States, European Union for the following indications:

🇺🇸 Approved in United States as High-definition transcranial direct current stimulation for: